ChemoCentryx Inc (CCXI) Q3 2020 Earnings Call Transcript
CCXI earnings call for the period ending September 30, 2020.
Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.
CCXI earnings call for the period ending September 30, 2020.
CCXI earnings call for the period ending June 30, 2020.
CCXI earnings call for the period ending March 31, 2020.
CCXI earnings call for the period ending December 31, 2019.
Positive trial results are always a good thing, but is this newly hyped stock worth it?
The company unveiled positive data for the most advanced drug in its pipeline.
Find out how three stocks in very different sectors all posted solid gains.
CCXI earnings call for the period ending September 30, 2019.
Stocks of drug developers, particularly small ones, can skyrocket or crater based on late-stage clinical trials. Before year-end, ChemoCentryx may do one or the other.
CCXI earnings call for the period ending June 30, 2019.